Major players in the patient blood management market are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc. , B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, Kaneka Corporation, and Bio-Rad Laboratories Inc.
New York, May 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Patient Blood Management Global Market Report 2022" - https://www.reportlinker.com/p06280853/?utm_source=GNW
The global patient blood management market is expected to grow from $11.83 billion in 2021 to $12.82 billion in 2022 at a compound annual growth rate (CAGR) of 8.4%. The market is expected to grow to $15.94 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%.
The market for patient blood management consists of sales of instruments, accessories, software, reagents, and kits used in the management of blood and blood products of patients. Patient blood management is a patient-focused, evidence-based and systematic approach to optimize care of patients, who might need a blood transfusion, by optimizing patients’ blood, minimizing surgical blood loss, and harnessing the patient-specific physiological reserve of anemia thereby reducing the need for allogeneic blood transfusions.
The patient blood management market is segmented by product into instruments, accessories, reagents and kits, software.The patient blood management kits are used to manage the patient’s blood.
It is also segmented by component into plasma, whole blood, and red blood cells that are used for applications such as hospitals, clinics, and others.
The rising number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market. According to WHO, 1.35 million people die every year due to road accidents, and low-income and middle-income countries account for 93% of the fatalities occurring in the world due to road accidents. According to the Centers for Disease Control and Prevention, 2019 show that 31.7% of all births were by cesarean and 25.6% of the NTSV population had cesarean births. Increased number of accidents, trauma cases, and surgical procedures resulted in increased demand for blood, and its products are driving the global patient blood management market.
The high cost associated with automated systems is expected to limit the growth of the global patient blood management market.Costs associated with an increasing regulatory requirement, infection testing, and hospital administration, which include initial project costs, personnel salaries, costs of equipment, outside resources, and ongoing project costs make automation expensive.
According to the Eastern Mediterranean Health Journal 2019, the expected cost of transfusion of one unit of red cells is US$700–$1200. The high economic cost of automation is therefore expected to hamper the global patient blood management market.
HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss.Clinicians can economically collect sterile, anticoagulated blood without any need for specialized resources.
By this, the upfront shed blood collection cost decreases, allogenic transfusions can be avoided with improved outcomes such as decreased patient mortality, low incidence of infections, and reduced risk of multi-organ failure. In August 2019, Ecomed Solutions, the developer and manufacturer of HEMAsavR received a contract from Vizient Inc, a healthcare performance improvement company to recommend HEMAsavR by hospital experts who serve as a Vizient member council.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the patient blood management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Read the full report: https://www.reportlinker.com/p06280853/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001